Sign in

CIK 0001740279 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

IN8BIO, INC.

Sign in to watch
Ticker
INAB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
825462585
Phone
(646) 600-6438
Business address
EMPIRE STATE BUILDING, 350 5TH AVENUE, SUITE 5330, NEW YORK, NY, 10118
Former names
Incysus Therapeutics, Inc.
  1. SC 13D/A Stake Beneficial Ownership Report
  2. SC 13G Stake Amended Statement of Ownership
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. 4 Insider Changes in Ownership
  8. 4 Insider Changes in Ownership
  9. 8-K Event Material agreement · Unregistered share sale · Shareholder rights changed
  10. SC 13G/A Stake Amended Statement of Ownership
  11. 8-K Event Executive or director change
  12. 8-K Event Executive or director change
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 8-K Event Exit or restructuring costs · Other events
  19. 424B5 Offering Prospectus
  20. 8-K Event Other events

Page 8 of 21 · 412 filings